| Literature DB >> 33815971 |
Abdullah A Alzayed1, Amani S Alotaibi1, Rahaf F Alfadhli1, Renad A Alageel1, Wejdan S Al-Saqat1, Hussain A Alghadeer2.
Abstract
Background Asthma is a common public health issue in the pediatric population. The prevalence of asthma in children in Saudi Arabia is increasing. All asthmatic children with continuous symptoms should use controller medications. These medications if used correctly by the patients will diminish the symptoms and avoid exacerbations that lead to hospitalization. Perception of parents toward a particular device can affect the adherence rate. Aim Assessing the parental perception about metered-dose inhalers (MDIs) and nebulizers differences among the Saudi population. Methods A cross-sectional study was conducted to assess Parental perception about MDIs and nebulizers among Saudi parents with an asthmatic child. The data were collected from the parents and caregivers by using an online questionnaire and informed consent was obtained. The questionnaire was focused on demographic characteristics, knowledge, perception and practice of treating the asthmatic child. Data were analyzed through the Statistical Package for the Social Sciences (SPSS) version 25 (IBM Corp., Armonk, NY) and the results were considered statistically significant if P < 0.05. Results A total of 1,021 participants included in this study. This study found asthma is predominant in males (64.4%) and the most affected age is between 8 and 14 years (56.3%). More than half of the parents (58.7%) had a bachelor's degree and above. MDI is the most method used for controlling asthma (32.7%) and the majority of them (70.2%) thought there is a therapeutic difference between MDI and nebulizer. Providing instructions and information on usage MDI was received from 65.2%. Significant relationships were found between the level of satisfaction and receiving enough information about MDI and level of education. Conclusion This study found that asthma is more prevalent in males, where MDI is more common. Majority of the parents had thought that there is a difference in the therapeutic effects between MDI and nebulizer. They believed that nebulizer is more effective, less side effect and cheaper while MDI is easier to use.Entities:
Keywords: asthma; mdi; nebulizer; pediatric; perception
Year: 2021 PMID: 33815971 PMCID: PMC8007121 DOI: 10.7759/cureus.13548
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Demographic data of participants.
| N (%) | ||
| Age of child | <7 | 446 (43.7) |
| 8-14 | 575 (56.3) | |
| Child's gender | Male | 658 (64.4) |
| Female | 363 (35.6) | |
| Age of caregiver | 19-29 years | 318 (31.1) |
| 30 years and above | 703 (68.9) | |
| Level of education | Primary/intermediate school level | 178 (17.4) |
| High school | 244 (23.9) | |
| Bachelor degree and above | 599 (58.7) | |
Figure 1Treatment options which are providing to child as a treatment for bronchial asthma.
MDI: metered-dose inhaler.
Perception of parents of using MDIs and nebulizers.
MDIs: metered-dose inhalers.
| Yes, N (%) | No, N (%) | |
| Do you think there is a difference in the therapeutic effect between MDIs and nebulizers in the treatment of bronchial asthma? | 717 (70.2) | 304 (29.8) |
| If you are using MDI, did you receive enough education from healthcare provider (nurse, doctor, health educator) on how to use it? | 666 (65.2) | 355 (34.8) |
| Do you believe that the asthmatic child who is using MDI will be lifelong dependent on this treatment? | 440 (43.1) | 581(56.9) |
Figure 2Difference of perception of parent between MDIs and nebulizers.
MDIs: metered-dose inhalers.
Satisfaction of parents and their perception about the MDIs and nebulizers.
*Significant at P-value <= 0.05. MDI: metered-dose inhaler.
| How satisfied are you with using the MDI, from 1 to 10? | How satisfied are you with using the nebulizer, from 1 to 10? | |||
| Mean (standard deviation) | Mean (standard deviation) | P-value | ||
| How old is your child | <7 | 5.61 (2.72) | 6.30 (2.68) | 0.000* |
| 8-14 | 6.31 (2.46) | 6.84 (2.57) | ||
| What is your child's gender? | Male | 6.19 (2.57) | 6.70 (2.57) | 0.005* |
| Female | 5.69 (2.62) | 6.43 (2.72) | ||
| How old is the caregiver? | 19-29 years | 5.95 (2.72) | 6.48 (2.72) | 0.621 |
| 30 years and above. | 6.04 (2.54) | 6.66 (2.58) | ||
| What is your level of education? | Primary/intermediate school level | 5.40 (2.81) | 6.20 (2.82) | 0.000* |
| High school | 6.00 (2.50) | 6.69 (2.45) | ||
| Bachelor degree and above | 6.21 (2.54) | 6.70 (2.63) | ||
| Did you receive enough education from healthcare providers (nurse, doctor, health educator) on how to use it? | Yes | 6.38 (2.58) | 0.000* | |
| No | 5.28 (2.47) | |||
| Which of the following do you think had more therapeutic effect for treatment of asthma? | MDI | 6.41 (2.59) | 6.38 (2.40) | 0.001* |
| Nebulizer | 5.67 (2.48) | 6.79 (2.72) | ||
| Equal effect | 6.18 (2.74) | 6.53 (2.68) | ||
| In your opinion, which of the following is easier to use? | MDI | 6.53 (2.38) | 6.68 (2.45) | 0.000* |
| Nebulizer | 5.04 (2.62) | 6.53 (2.92) | ||
| No difference | 5.66 (2.78) | 6.50 (2.75) | ||
| Which of the following modalities of treatment have more side effects? | MDI | 5.71 (2.60) | 6.60 (2.66) | 0.001* |
| Nebulizer | 6.23 (2.54) | 6.19 (2.78) | ||
| No difference | 6.23 (2.60) | 6.82 (2.49) | ||
| Which of the following modalities has more cost to afford? | MDI | 5.8 (2.60) | 6.48 (2.66) | 0.000* |
| Nebulizer | 6.28 (2.57) | 6.77 (2.58) | ||
The relationship between demographic factors and perception of parents.
*Significant at P-value <= 0.05. MDI: metered-dose inhaler.
| How old is your child | What is your child's gender? | How old is the caregiver? | What is your level of education? | |||||||
| <7 | 8-14 | Male | Female | 19-29 years | 30 years and above | Primary | High school | Bachelor degree | ||
| Do you think there is a difference in the therapeutic effect between MDI and nebulizers in the treatment of bronchial asthma? | Yes | 42.3% | 57.7% | 65.0% | 35.0% | 30.3% | 69.7% | 16.2% | 23.2% | 60.7% |
| No | 47.0% | 53.0% | 63.2% | 36.8% | 33.2% | 66.8% | 20.4% | 25.7% | 53.9% | |
| P-value | 0.159 | 0.575 | 0.351 | 0.122 | ||||||
| Which of the following do you think had more therapeutic effect for treatment of asthma? | MDI | 46.4% | 53.6% | 62.5% | 37.5% | 30.9% | 69.1% | 17.5% | 20.3% | 62.2% |
| Nebulizer | 43.9% | 56.1% | 66.0% | 34.0% | 28.4% | 71.6% | 18.4% | 25.8% | 55.8% | |
| Equal effect | 40.3% | 59.7% | 63.8% | 36.2% | 36.2% | 63.8% | 15.7% | 24.6% | 59.7% | |
| P-value | 0.345 | 0.605 | 0.088 | 0.361 | ||||||
| If you are using MDI, did you receive enough education from healthcare provider (nurse, doctor, health educator) on how to use it? | Yes | 41.6% | 58.4% | 65.5% | 34.5% | 32.4% | 67.6% | 17.0% | 24.0% | 59.0% |
| No | 47.6% | 52.4% | 62.5% | 37.5% | 28.7% | 71.3% | 18.3% | 23.7% | 58.0% | |
| P-value | 0.065 | 0.352 | 0.224 | 0.856 | ||||||
| In your opinion, which of the following is easier to use? | MDI | 39.9% | 60.1% | 66.0% | 34.0% | 28.3% | 71.7% | 15.5% | 21.5% | 63.0% |
| Nebulizer | 50.4% | 49.6% | 63.9% | 36.1% | 28.3% | 71.7% | 18.3% | 30.4% | 51.3% | |
| No difference | 46.5% | 53.5% | 60.9% | 39.1% | 41.9% | 58.1% | 21.9% | 23.3% | 54.9% | |
| P-value | 0.016* | 0.412 | 0.001* | 0.008* | ||||||
| Do you believe that the asthmatic child who is using MDI will be lifelong dependent on this treatment? | Yes | 46.8% | 53.2% | 65.2% | 34.8% | 35.2% | 64.8% | 20.9% | 23.9% | 55.2% |
| No | 41.3% | 58.7% | 63.9% | 36.1% | 28.1% | 71.9% | 14.8% | 23.9% | 61.3% | |
| P-value | 0.079 | 0.650 | 0.014* | 0.031* | ||||||
| Which of the following modalities of treatment have more side effects? | MDI | 47.4% | 52.6% | 63.6% | 36.4% | 29.1% | 70.9% | 16.9% | 21.1% | 62.0% |
| Nebulizer | 41.7% | 58.3% | 67.7% | 32.3% | 33.3% | 66.7% | 21.4% | 23.4% | 55.2% | |
| No difference | 40.6% | 59.4% | 63.8% | 36.2% | 32.4% | 67.6% | 16.1% | 27.3% | 56.6% | |
| P-value | 0.117 | 0.577 | 0.449 | 0.132 | ||||||
| Which of the following modalities has more cost to afford? | MDI | 45.7% | 54.3% | 67.2% | 32.8% | 29.0% | 71.0% | 16.8% | 23.1% | 60.1% |
| Nebulizer | 41.1% | 58.9% | 60.9% | 39.1% | 33.9% | 66.1% | 18.2% | 24.9% | 56.9% | |
| P-value | 0.147 | 0.037* | 0.091 | 0.586 | ||||||